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INTRODUCTION 
D
isintegration of the former SFRY, which begun with the warfare in 1991, sanctions
imposed by the United Nations towards SFRY from 1992 to 2002, and military opera-
tions of NATO countries against SRY in 1999 caused the breakup of local, national, eco-
nomic, social, cultural, scientific, and technology programs and activities. These were also
the reasons for a significant decline in scientific community and the number of scientific
researches in biomedicine and the number of published papers from basic and clinical
oncology was reduced. Only Rajko Igi￿ in his study from 2001 has reported a bibliometric
analysis of the number of published articles in journals printed in former SFRY that are cited
in the Science Citation Index (SCI); the results of this study point to a significant fall of sci-
entific production (1). In the countries of the European Union (EU): France, Germany, and
Greece bibliometric factors show a progressive increase of the citation index and the impact
factor of oncology journals in the period from 1996 to 2000; however, they also show the
lagging of European biomedical and oncology publications behind those in the USA (2).
Analysis of citations evaluates scientific and research work and defines the impact of this
work in certain scientific filed (3). These analyses have been based on the data of the
Institute for Scientific Information (ISI), which keeps evidence of more than 1,400 medical
journals. Such reports evaluate the work of scientists, scientific units, institutions, and
countries. They are valuable in the identification of the research or for the survey of the his-
tory of oncology disciplines (4).
The purpose of this study was to analyze the papers related to oncology published and the
frequency of key words used in four leading medical journals in Serbia for the period 1996-
2000; these bibliometric factors were correlated with socioeconomic variables (4).  
MATERIALS AND METHODS
This retrospective study was based on the data on scientific papers published in the fol-
lowing journals: Srpski Arhiv za Celokupno Lekarstvo, Vojnosanitetski Pregled, Medicinski
pregled, and Archive of Oncology, from 1995 to 2000. Bibliographic analysis included all
review articles, editorials, actual problems, case reports, letters to the editor, and the con-
tents of special supplements. All papers with foreign authors were excluded from the analy-
sis. The frequency of used key words was also calculated. The number of inhabitants in
Serbia is given in millions and gross domestic products (GDP) is expressed in million of US
dollars; both parameters did not include data on Kosovo and Metohija (5).
RESULTS 
Quantitative analysis showed that the total of 855 oncology articles were published in med-
ical and oncology journals during a 5-year period (1995-2000) (Table 1). Only 55 papers
were published during the NATO military operation in 1999, in SRY; this number slightly
increased to 63 in 1997under the long-term UN sanctions. 
In EU, a total of 4,063 articles were published in 1995 and 4,842 papers in 2000 (2,4).
During the same period 2,468 biomedical articles were published in Serbia, of which 855
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Montenegrowere oncology papers (30.64%). The largest number of papers was published in the jour-
nal Vojnosanitetski Pregled (27.99%); oncology-related papers were most numerous in the
Archive of Oncology - 791 (92.51%). As compared to EU, 0.45% biomedical articles and
3.64% oncology papers were published in our country (Table 1,2).
One hundred and ninety-nine oncology articles were published in Serbia in 1995 and that
was more than in Spain (117), Denmark (106), Belgium (97), Austria (93), Finland (91),
Greece (91), Norway (91), Ireland (26), Portugal (13), and Luxembourg for the same year
(2). However, in the year 2000 one hundred and seventeen articles were published in our
country; behind were Denmark (115), Austria (110), Finland (115), Norway (90), and
Ireland, Portugal and Luxembourg with almost unchanged number of published papers in
comparison to 1995. 
The ratio between the number of published oncology articles and the number of inhabitants
for the observed period is presented in Table 3.
In the USA the same ration was19.5, in the EU 12.5, and in it was Serbia 0.00024, which
put us behind Portugal and Luxembourg (2,4). The ration between published papers and
GDP showed the score of 0.6 in the EU, 0.7 in the USA, and 0.10 in Serbia (Table 4) (4).
Research topics
In oncology text the authors used the total of 5,130 different key words, approximately 6
words per paper. Among them the most frequent were 1,266 key words such as: breast
cancer (20.77%), radiotherapy (10.3%), immunohistochemistry (14.3%), colorectal cancer
(6.32%), apoptosis (4%), etc. (Table 5). Apart from standard key words nonstandard key
words were also used, e.g. synonyms (cancer vs. carcinoma, apoptosis vs. cell death or
programmed cell death), spelling variations (tumor vs. tumor) specific terminology (tumor
suppressor gene vs. p53), and abbreviations (MRI/NMRI, 5-FU, BRCA-1)
The key words were the basis for identification of references, which enabled the tracking of
the trends in researching. Table 5 shows the top key words related to diseases, antitumor
drugs, treatments, and research topics and related techniques.
DISCUSSION
During the period 1995-2000 the number of the published biomedical papers in Serbia was
modest - 2,468, which presented 0.40% of biomedical production in the EU.  The percent
of published oncology papers in comparison to EU was 3.64; the majority of these papers
(92.7%) were published in the Archive of Oncology.
However, the publication of scientific papers in EU countries was higher than in the USA
and showed a continuous increase since 1981, mainly due to the growing number of clin-
ical trials (2). The most productive publication of oncology papers among the EU countries
is in England, Germany, France, Italy, and The Netherlands. It should be noted that in small-
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Table1. Number of published biomedical papers in Serbia
Table 2. Number of oncology papers published in Serbia
Table 3. Ratio between the number published papers and the number of inhabitants in Serbia
Table 4. Ratio between the number of publishe papers and Gross Domestic Products (GDP) in
Serbia
Table 5. Analysis of key words for oncology publicationImpact assessment of oncology literature
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er EU countries, such as Greece, Belgium, and Spain, the publication of oncology texts is
continuously increasing. Contrary to these trends the publication of biomedical and oncol-
ogy articles in Serbia during the observed period was LOW due to UN sanctions and mili-
tary operations of NATO countries in 1999. 
According to Igic the biomedical publication in the countries of the former SFRY, including
Serbia, was diminished because of the warfare in Bosnia and Herzegovina, Croatia, and
Slovenia. Therefore, we could say that bibliometric indicators are very sensitive in tracing
of local and international political issues including warfare (1). The declining trend in the
publication of biomedical articles was also caused by the brain drain, publication of papers
in foreign journals, and insufficient financial support for scientific research in biomedicine.
I believe that Serbian, the language used for writing the majority of biomedical papers, and
English, the language in which the majority of papers are printed in the Archive of Oncology,
did not have any impact on the scope of oncology publication.
However, the languages of great European nations such as French or German do have an
impact to the bibliometric assessment and ranging because journals printed in these coun-
tries are not registered in the ISI database, which is entirely in English. 
The ratio between oncology papers published in Serbia and the number of inhabitants is
0.00031%. This ration is not real because the number of the inhabitants in Kosovo and
Metohija, which is under the protectorate of the UN since 1999, has not been included in
the calculation. Such low publication production has also been recorded in Luxembourg in
1995 and 1998 and in Portugal in 1998 (2). In the EU the percent of the oncology publica-
tions is 12.5 and leading countries are those from Scandinavia and the Netherlands.
In Serbia the ratio between the number of oncology papers and GDP is very low - only
0.10% due to low publishing production. 
In the countries of EU the ratio is 0.6%. The greatest is in the Scandinavian countries, the
Netherlands, Greece, UK, and Italy. Small countries of the EU have a high ratio between the
published papers and GDP due to high GDP (2,4).
Serbia is a small European country with a surface of 5,783,745 km2. In 2000, GDP in
Serbia was 1,935 US dollars per citizen (5); the highest GDP was in 1997 - 1,549 US dol-
lars per citizen (5).
The analysis of the frequency of key words showed a great dispersion. About 30.5% of key
words were used more than once and only 1% very rarely. This problem has been noticed
in the biomedical production in different disciplines, both in the EU and in the world (2,6).
The most frequently used key words were: breast cancer, colorectal cancer, and carcino-
ma of the bronchi. The same sequence of key words frequency has been found in the
oncology papers published in the countries of the EU (2,4).  Key words from the field of
chemotherapy point to the current clinical settings. In the oncology journalism in Serbia the
most frequently used key word is radiotherapy (RT); the next are surgery, chemotherapy,
or combined treatment regimens. The same frequency has been observed in the scientific
journalism in the EU countries (2,4). In clinical trials the most frequently applied are the
immunohistochemical methods (14.3%); apoptosis was the most investigated topic of
experimental research.
This study is insufficient and limited. The obtained data are neither based on ISI database
nor there is a database of biomedical and oncology journals of the Republic of Serbia. Such
database is currently in the process of creation (personal communication, Pero 'ipka,
Faculty of Philosophy, University of Novi Sad). The second limitation is related to present-
ed and published oncology papers in basic disciplines, e.g., immunology, genetics, and
biochemistry, and published papers from clinical oncology - the branches of maxillofacial
surgery, respiratory and digestive system, uropoietic system, hematopoietic system, and
CNS. All data have been published in the proceedings, with a heterogeneous assessment
of the form, contents, and the use of key words.
Third limitation refers to the publishing outside Serbia, in leading European or world jour-
nals. These data have been mostly collected from the university centers in Serbia (Belgrade,
Novi Sad, Nis, and Kragujevac) and there is no and accessible database. Database at the
level of the republic is being in the process of creation. 
This analysis was deficient because it was not possible to express impact factor, which is
an important bibliometric parameter for all journals. The analyzed journals published in
Serbia are not referred in ISI database and have a low citation index; the Archive of
Oncology has been published for 8 years only (7). It is expected that the national biomed-
ical database will be the source of citation, impact factors, and other resources for valid
bibliometric analysis of journals and comparative with the contents of Eurostat. 
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